A new study suggests that both physicians and patients can benefit from robotic-assisted PCI. This research, which was published in the July issue of the Journal of Invasive Cardiology, compares traditional PCI to robotic-assisted PCI. The findings of this study suggest that robotic-assisted PCI compares favorably to the traditional approach, reducing physician radiation exposure significantly while indicating a trend towards reduction in overall fluoroscopy time and contrast volume.

In her recent article, Arhundati Parmar spoke with David Handler, President & CEO of Corindus Vascular Robotics, to learn more about the CorPath Vascular Robotic System. She highlights some of the key benefits of CorPath including reduced radiation to the physician and robotic precision when placing stents to potentially improve clinical outcomes for the patient.

We are pleased to announce the recent installation of CorPath Systems at five facilities across the United States: UH Case Medical Center, Cleveland, OH; Virginia Commonwealth University Medical Center, Richmond, VA; Miami Cardiac & Vascular Institute, Miami, FL; the second system in Michigan and first system in North Carolina. In addition, Corindus announced that customers used CorPath in a record number of cases in the quarter ending June 2014, the third straight quarter of record-setting utilization.